Biosimilar Education and Outreach
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $250,000 to $700,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 561499 All Other Business Support Services
- Points of contact
-
- CDER Acquisition Liaison cderacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is forecasting a new requirement for Biosimilar Education and Outreach support services classified under All Other Business Support Services (NAICS 561499). The contract will provide continued support for comprehensive, data-driven education and outreach initiatives designed to improve awareness and understanding of biosimilars among patients, providers, and stakeholders. The solicitation is estimated to be released on October 1, 2025, with an anticipated award date of April 1, 2026.
The estimated award value for this contract ranges from $250,000 to $700,000. No set-aside provisions apply to this procurement. For inquiries or to obtain additional information regarding this opportunity, interested parties should contact the FDA's Acquisition Liaison at cderacquisitions@fda.hhs.gov.
Forecast text
Continued contract support to deliver comprehensive, data-driven education and outreach initiatives and activities that improve awareness and understanding of biosimilars among patients, providers, and stakeholders.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast